| The Promise Of Low Dose Naltrexone Therapy: Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders |  | Author: Elaine A. Moore
Creators: Dr. Yash P. Agrawal, Samantha Wilkinson
Publisher: McFarland
Category: Book
List Price: $35.00
Buy New: $33.33
as of 5/27/2012 03:08 EDT details
You Save: $1.67 (5%)
New (18) Used (16) from $31.66
Seller: Amazon.com
Sales Rank: 48,615
Languages: English (Unknown), English (Original Language), English (Published)
Media: Paperback
Pages: 223
Number Of Items: 1
Shipping Weight (lbs): 0.8
Dimensions (in): 8.8 x 5.9 x 0.7
ISBN: 0786437154
EAN: 9780786437153
ASIN: 0786437154
Publication Date: December 1, 2008
Shipping: Eligible for FREE Super Saver Shipping
Availability: Usually ships in 24 hours
| |
| Also Available In:
|
| Similar Items:
| |
| Editorial Reviews:
Product Description
Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to halt disease progression in Crohn's disease and certain cancers, to reduce symptoms in multiple sclerosis and autism, and to improve numerous autoimmune and neurodegenerative conditions, including Parkinson's disease and amyotrophic lateral sclerosis (ALS).
Grounded in clinical and scientific research, this book describes the history of naltrexone, its potential therapeutic uses, its effects on the immune system, its pharmacological properties, and how the drug is administered. It also lists fillers and compounding pharmacies, doctors who prescribe LDN, and patient resources, and includes interviews with LDN patients and researchers.
|
| |
|
|
|
CERTAIN CONTENT THAT APPEARS ON THIS SITE COMES FROM AMAZON SERVICES LLC. THIS CONTENT IS PROVIDED ‘AS IS’ AND IS SUBJECT TO CHANGE OR REMOVAL AT ANY TIME. Powered by Associate-O-Matic
| |
